ABBV
AbbVie
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ABBV
- PE Ratio
As at Jun 5, 2026, the ABBV stock has a PE ratio of 111.94. This is based on the current EPS of $2.03 and the stock price of $227.23 per share. A decrease of 3.8% has been seen in the P/E ratio compared to the average of 116.4 of the last 4 quarters.
ABBV PE ratio history
The mean historical PE ratio of AbbVie over the last ten years is 39.81. The current 111.94 PE ratio is 181% above the historical average. Over the past ten years, ABBV's PE ratio was at its highest in the Sep 2025 quarter at 174.09, with a price of $231.54 and an EPS of $1.33. The Mar 2020 quarter recorded the bottom point at 13.44, with a price of $76.19 and an EPS of $5.67.
AbbVie PE ratio by year
Maximum annual increase: 187.98% in 2014
Maximum annual decrease: -68.09% in 2015
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 96.41 | 30.21% | $228.49 | $2.37 |
| 2024 | 74.04 | 30.42% | $177.7 | $2.4 |
| 2023 | 56.77 | 133.62% | $154.97 | $2.73 |
| 2022 | 24.3 | 16.27% | $161.61 | $6.65 |
| 2021 | 20.9 | -46.75% | $135.4 | $6.48 |
| 2020 | 39.25 | 134.89% | $107.15 | $2.73 |
| 2019 | 16.71 | -33.48% | $88.54 | $5.3 |
| 2018 | 25.12 | -14.03% | $92.19 | $3.67 |
| 2017 | 29.22 | 70.28% | $96.71 | $3.31 |
| 2016 | 17.16 | -8.77% | $62.62 | $3.65 |
| 2015 | 18.81 | -68.09% | $59.24 | $3.15 |
| 2014 | 58.95 | 187.98% | $65.44 | $1.11 |
| 2013 | 20.47 | N/A | $52.81 | $2.58 |
| 2012 | N/A | N/A | N/A | $3.35 |
| 2011 | N/A | N/A | N/A | $2.18 |
AbbVie PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 107.14 | 11.13% | $217.49 | $2.03 |
| Dec 2025 | 96.41 | -44.62% | $228.49 | $2.37 |
| Sep 2025 | 174.09 | 97.9% | $231.54 | $1.33 |
| Jun 2025 | 87.97 | -0.91% | $185.62 | $2.11 |
| Mar 2025 | 88.78 | 19.91% | $209.52 | $2.36 |
| Dec 2024 | 74.04 | 7.98% | $177.7 | $2.4 |
| Sep 2024 | 68.57 | 19.94% | $197.48 | $2.88 |
| Jun 2024 | 57.17 | 5.79% | $171.52 | $3 |
| Mar 2024 | 54.04 | -4.81% | $182.1 | $3.37 |
| Dec 2023 | 56.77 | 39.38% | $154.97 | $2.73 |
| Sep 2023 | 40.73 | 47.52% | $149.06 | $3.66 |
| Jun 2023 | 27.61 | -26.2% | $134.73 | $4.88 |
| Mar 2023 | 37.41 | 53.95% | $159.37 | $4.26 |
| Dec 2022 | 24.3 | 36.36% | $161.61 | $6.65 |
| Sep 2022 | 17.82 | -17.5% | $134.21 | $7.53 |
ABBV Price vs fair value
ABBV average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
ABBV's current P/E ratio is above the 3, 5 and 10-year historical averages.
PE comparison
With a P/E of 111.94, ABBV is above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 23.87, AbbVie's P/E is 369% higher.
ABBV PE vs peers
ABBV's PE ratio is higher than its peer stocks LLY and AZN. AbbVie's current PE ratio of 111.94 is above the average of its peers, which is 23.83.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BMY Bristol Myers Squibb Co | 16.04 | $116.95B |
| GILD Gilead Sciences Inc | 17.41 | $160.36B |
| PFE Pfizer Inc | 19.88 | $148.41B |
| BIIB Biogen Inc | 20.89 | $28.84B |
| AMGN Amgen Inc | 24.14 | $188.67B |
| NBIX Neurocrine Biosciences Inc | 24.42 | $16.48B |
| AZN Astrazeneca plc | 27.71 | $288.04B |
| LLY ELI LILLY & Co | 40.14 | $1.07T |
| ABBV AbbVie Inc | 111.94 | $401.47B |
Frequently asked questions
What is AbbVie's PE ratio?
As of Jun 5, 2026, ABBV stock has a price to earnings ratio of 111.94.
What is the 3-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 3 years is 77.78.
What is the 5-year average PE ratio for AbbVie (ABBV)?
The average PE ratio for ABBV stock over the past 5 years is 56.76.
What is the highest PE ratio for ABBV?
Over the last ten years, the quarterly PE ratio reached a historic high of 174.09 in the Sep 2025 quarter.
How does the current PE ratio for ABBV compare to its historical average?
ABBV's current price to earnings ratio is 181% above its 10-year historical average.
Why is AbbVie's PE ratio so high?
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
How is ABBV's PE ratio calculated (AbbVie PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 5, 2026), AbbVie's stock price is $227.23. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.03. Therefore, AbbVie's P/E ratio for today is 111.94. PE RATIO(111.94) = STOCK PRICE($227.23) / TTM EPS($2.03)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.